论文部分内容阅读
近年来,用胎肝细胞输注治疗急性白血病国内外均有报道,被认为是治疗急性白血病强烈化疗时的一种有力支持治疗。我院自1987年以来用胎肝脾胸腺细胞混合液联合化疗治疗骨髓增生异常综合征(MDS)9例,取得了良好疗效,现报道如下。材料与方法1.病例选择:治疗组9例,均系我院住院病人。男7例,女2例,年龄21～56岁,病程2～15月。依照FAB分型,原始粒细胞增多的难治性贫血(RAEB)
In recent years, the treatment of acute leukemia with fetal liver cells has been reported both at home and abroad, is considered to be a strong supportive treatment of acute leukemia during intensive chemotherapy. Since 1987, our hospital with fetal liver and spleen and thymocyte mixture combined chemotherapy in the treatment of myelodysplastic syndrome (MDS) in 9 cases, and achieved good results, are reported below. Materials and Methods 1. Case Selection: Treatment group, 9 cases, all in our hospital inpatients. 7 males and 2 females, aged 21 to 56 years old, duration of 2 to 15 months. According to FAB typing, refractory primary myeloproliferative anemia (RAEB)